3rd Annual Immunologix Bioanalysis Symposium
Register Today
Immunologix Laboratories is excited to announce our 3rd Annual Bioanalysis Symposium.
This year's program follows a single thread across the day: the science of fit-for-purpose bioanalysis. A biomarker or an immunogenicity assay is only as informative as its context-of-use, and how each is defined, validated, and interpreted determines whether the resulting data can support a development or regulatory decision.
Sessions move from context-of-use and integrated bioanalysis, through immunogenicity risk assessment across modalities, including peptides and oligonucleotides, and into the regulatory and scientific perspectives that shape the field. Each session closes with a panel, and the day ends with an extended discussion bringing all speakers together.
At Immunologix Laboratories, we believe that breakthrough science happens when brilliant minds come together.
Our list of speakers includes:
- Dr. Leslie Gordon, The Progeria Research Foundation
- Dr. Steven Piccoli, Sun Pharma Advanced Research (SPARC)
- Dr. John Canfield, Immunologix Laboratories
- Dr. Devangi Mehta, Immunologix Laboratories
- Dr. Vibha Jawa, Epivax
- Dr. Mohsen Rajabi, Novartis
- Dr. Michael Partridge, Regeneron
- Dr. Lauren Stevenson, Immunologix Laboratories
- Dr. Christopher Stebbins, CSL
- Dr. Susan Kirshner, Consultant, former FDA
- Dr. Daniela Verthelyi, Consultant, former FDA
October 1, 2026 | Le Méridien Boston Cambridge, 20 Sidney St, Cambridge, MA
This event is free.